孙曙明 中南大学 生命科学学院副教授，研究生导师，实验中心主任。

湖南师范大学生命科学学院博士（2011）；美国内布拉斯加医学院生物化学与分子生物学系交流学生（2009-2010）；美国纽约血液中心红系发育实验室博士后（2015-2016）；中南大学生命科学学院2016年评为副教授，硕士生导师。研究领域主要集中在（1）核酸适体的开发及应用研究，（2）血液肿瘤药物治疗及机制研究，以及（3）红系发育与铁代谢等相关研究。先后主持中央军委科技委创新培育项目两项，主持国家自然科学基金，中国博士后基金，湖南省自然科学基金及博士点基金等项目。目前为中央军委科技委专家库成员。中国生理学会血液学专业委员会青年会员，中国病理生理学会会员，湖南省生化与分子生物学学会会员。先后获得中南大学优秀班导师、“钢联物流”优秀班导师称号，所带班级获得“五四”红旗优秀班集体称号。多次获得中南大学工会“五一”表彰，获得中南大学课堂教学质量优秀奖。多次获得中南大学考核评价优秀个人等。

部分论文:

Li, S.; Wang, H.; Xiong, S.; Liu, J.; Sun, S. Targeted Delivery Strategies for Multiple Myeloma and Their Adverse Drug Reactions. Pharmaceuticals 2024, 17, 832.

Sun, S; Liu, H; Hu, Y; Wang, Y; Zhao, M; Yuan, Y; Han, Y; Jing, Y; Cui, J; Ren, X; Chen, X; Su, J, Selection and identification of a novel ssDNA aptamer targeting human skeletal muscle, Bioact Mater, 2023, 20: 166-178.

Liao, Yongkang; Xiong, Shijun; Ur Rehman, Zaid; He, Xiaoli; Peng, Hongling; Liu, Jing; Sun, Shuming, The Research Advances of Aptamers in Hematologic Malignancies, Cancers, 2023, 15(1): 300.

He, X; Liao, Y; Liu, J; Sun, S, Research Progress of Natural Small-Molecule Compounds Related to Tumor Differentiation, Molecules, 2022, 27(7).

Zhao Mingri; Yang Chaoying; Chai Siyu; Yuan Yijun; Zhang Ji; Cao Pengfei; Wang Yanpeng; X iao Xiaojuan; Wu Kunlu; Yan Huiwen; Liu Jing; Sun Shuming ; Curcumol and FTY720 synergistically i nduce apoptosis and differentiation in chronic myelomonocytic leukemia via multiple signaling pat hways, Phytotherapy Research, 2020, 10(1002): 1-14

Shen, Yu; Xiao, Xiaojuan; Wu, Kunlu; Wang, Yanpeng; Yuan, Yijun; Liu, Jianwei; Sun, Shumi ng; Liu, Jing; Effects and molecular mechanisms of Ninghong black tea extract in nonalcoholic fa tty liver disease of rats, Journal of Food Science, 2020, 85(3): 800-807

Li, H; Roy, M; Liang, L; Cao, W; Hu, B; Li, Y; Xiao, X; Wang, H; Ye, M; Sun, S; Zhang, B; Liu, J; Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multipl e myeloma by stabilizing HMGB1, Oncogene, 2022, 41(9): 1298-1308

Liao, Z; Li, J; Wu, J; Liu, J; Sun, S, Chemotherapeutics for Acute Erythroid Leukemia: Research, Present and Future, Current Molecular Medicine, 2021, 21(10): 819-831.